A company insider recently sold 2,392 shares of Revance Therapeutics Inc [RVNC]. Should You Sale?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Revance Therapeutics Inc shares valued at $9,096 were sold by Jordan Erica on Apr 16 ’24. At $3.80 per share, Jordan Erica sold 2,392 shares. The insider’s holdings dropped to 114,864 shares worth approximately […]
Investing in Revance Therapeutics Inc (RVNC) Is Getting More Attractive
Revance Therapeutics Inc’s recent filing unveils that its CFO Schilke Tobin unloaded Company’s shares for reported $47204.0 on Mar 18 ’24. In the deal valued at $5.04 per share,9,361 shares were sold. As a result of this transaction, Schilke Tobin now holds 192,666 shares worth roughly $0.8 million. Then, Sjuts Dustin S sold 9,211 shares, […]
RVNC Stock Sees Decline of Approximately -3.08% in Last Five Days
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Revance Therapeutics Inc shares valued at $47,204 were sold by Schilke Tobin on Mar 18 ’24. At $5.04 per share, Schilke Tobin sold 9,361 shares. The insider’s holdings dropped to 192,666 shares worth approximately $0.85 million following […]
Mizuho downgrades Revance Therapeutics Inc (RVNC) rating to a Neutral
Revance Therapeutics Inc’s recently made public that its CFO Schilke Tobin unloaded Company’s shares for reported $47204.0 on Mar 18 ’24. In the deal valued at $5.04 per share,9,361 shares were sold. As a result of this transaction, Schilke Tobin now holds 192,666 shares worth roughly $0.85 million. Then, Sjuts Dustin S sold 9,211 shares, […]
Positive sentiment towards RVNC reflected in decline in short interest
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Revance Therapeutics Inc shares valued at $47,204 were sold by Schilke Tobin on Mar 18 ’24. At $5.04 per share, Schilke Tobin sold 9,361 shares. The insider’s holdings dropped to 192,666 shares worth approximately $0.88 million following […]
A Guide To The Risks Of Investing In Revance Therapeutics Inc (RVNC)
Revance Therapeutics Inc’s recently made public that its CFO Schilke Tobin unloaded Company’s shares for reported $47204.0 on Mar 18 ’24. In the deal valued at $5.04 per share,9,361 shares were sold. As a result of this transaction, Schilke Tobin now holds 192,666 shares worth roughly $0.95 million. Then, Sjuts Dustin S sold 9,211 shares, […]
Taking a look at what insiders are doing to gauge the Revance Therapeutics Inc [RVNC]’s direction
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Revance Therapeutics Inc shares valued at $47,204 were sold by Schilke Tobin on Mar 18 ’24. At $5.04 per share, Schilke Tobin sold 9,361 shares. The insider’s holdings dropped to 192,666 shares worth approximately […]
Understanding the Risks of Investing in Revance Therapeutics Inc (RVNC)
Revance Therapeutics Inc’s filing revealed that its CFO Schilke Tobin unloaded Company’s shares for reported $47204.0 on Mar 18 ’24. In the deal valued at $5.04 per share,9,361 shares were sold. As a result of this transaction, Schilke Tobin now holds 192,666 shares worth roughly $0.94 million. Then, Sjuts Dustin S sold 9,211 shares, generating […]
